On Tuesday, Quest Diagnostics, Inc (NYSE: DGX) opened lower -0.46% from the last session, before settling in for the closing price of $168.00. Price fluctuations for DGX have ranged from $125.42 to $178.87 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 5.68% annually for the last half of the decade. Company’s average yearly earnings per share was noted 8.45% at the time writing. With a float of $111.03 million, this company’s outstanding shares have now reached $111.61 million.
In an organization with 56000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 32.41%, operating margin of 13.98%, and the pretax margin is 11.9%.
Quest Diagnostics, Inc (DGX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Quest Diagnostics, Inc is 0.52%, while institutional ownership is 90.91%. The most recent insider transaction that took place on Apr 02 ’25, was worth 6,602,074. In this transaction CEO and President of this company sold 39,191 shares at a rate of $168.46, taking the stock ownership to the 127,623 shares. Before that another transaction happened on Apr 02 ’25, when Company’s SVP, Clinical Solutions sold 2,555 for $170.00, making the entire transaction worth $434,350. This insider now owns 10,575 shares in total.
Quest Diagnostics, Inc (DGX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.55 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 8.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.43% during the next five years compared to 4.04% growth over the previous five years of trading.
Quest Diagnostics, Inc (NYSE: DGX) Trading Performance Indicators
Check out the current performance indicators for Quest Diagnostics, Inc (DGX). In the past quarter, the stock posted a quick ratio of 1.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.89. Likewise, its price to free cash flow for the trailing twelve months is 20.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.70, a number that is poised to hit 2.15 in the next quarter and is forecasted to reach 10.52 in one year’s time.
Technical Analysis of Quest Diagnostics, Inc (DGX)
Let’s dig in a bit further. During the last 5-days, its volume was 1.87 million. That was better than the volume of 1.22 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 54.80%. Additionally, its Average True Range was 4.93.
During the past 100 days, Quest Diagnostics, Inc’s (DGX) raw stochastic average was set at 61.42%, which indicates a significant increase from 59.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 27.07% in the past 14 days, which was higher than the 22.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $168.63, while its 200-day Moving Average is $156.64. However, in the short run, Quest Diagnostics, Inc’s stock first resistance to watch stands at $169.07. Second resistance stands at $170.91. The third major resistance level sits at $172.13. If the price goes on to break the first support level at $166.01, it is likely to go to the next support level at $164.79. The third support level lies at $162.95 if the price breaches the second support level.
Quest Diagnostics, Inc (NYSE: DGX) Key Stats
There are currently 110,978K shares outstanding in the company with a market cap of 18.66 billion. Presently, the company’s annual sales total 9,872 M according to its annual income of 871,000 K. Last quarter, the company’s sales amounted to 2,621 M and its income totaled 222,000 K.
